IVD company executives noted that the acceptance and acceleration of decentralized care models have increased, enabling more effective testing for many conditions.
According to industry insiders, the UK has the chance to set new policies that will both keep the domestic IVD market safe, while keeping the country internationally competitive.
The test measures a panel of proteins in patient blood to determine if they have a bacterial or viral infection, or if they have a bacterial-viral co-infection.
The Delta variant of SARS-CoV-2 has boosted COVID-19 testing, but the severity of the coming flu season and the need for combo tests remain unpredictable.
Mecwins Developing 'Highly Sensitive' Plasmonic Testing Tech for Laboratories, Point of Care
Premium
The firm recently inked an agreement with Quidel to enable the codevelopment of its technology for testing in doctors' offices and other decentralized settings.
Seattle-based ID Genomics is partnering with a diagnostics instrument developer to adapt its genetic fingerprinting methods for point-of-care use.
Researchers used the amplicon-based LiquidHallmark test to correlate tumor DNA changes with treatment response.